Diagnostic and prognostic value of vasodilator stress echocardiography in asymptomatic Type 2 diabetic patients with positive exercise thallium scintigraphy: A pilot study

Diabetic Medicine

Volumn 16, Issue 9, 1999, Pages 762-766

  Gaddi, O ^b   Tortorella, G ^b   Picano, Eugenio ^a,c   Pantaleoni, M ^b   Manicardi, E ^b   Varga, A ^a   Moneta, I ^a   Guiducci, U ^b  

^a CNR   (Italy)

^b Cardiology Division   (Italy)

^c INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Diabetes; Ischaemic heart disease; Stress echocardiography

Indexed keywords

THALLIUM;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; EXERCISE TEST; FOLLOW UP; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROGNOSIS; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY;

CORONARY ANGIOGRAPHY; DIABETES MELLITUS, TYPE 2; DIPYRIDAMOLE; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASODILATOR AGENTS;

EID: 0032886599     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.1999.00145.x     Document Type: Article

References (19)

1. Chiariello M, Indolfi C. Silent myocardial ischaemia in patients with diabetes mellitus. Circulation 1996; 93: 2089-2091.
2. Nesto RW, Philllips RT, Kett KG, Hill T, Perper E, Young E et al. Angina and exertional myocardial ischemia in diabetic patients; assessment by exercise thallium scintigraphy. Ann Intern Med 1988; 108: 170-175.
3. Milan Study on Atherosclerosis and Diabetes (MiSAD) Group. Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in noninsulin-dependent diabetes mellitus. Am J Cardiol 1997; 79: 134-139.
4. Diamond GA. How accurate is SPECT thallium scintigraphy? J Am Coll Cardiol 1990; 16: 1017-1021.
5. Picano E. Stress echocardiography: from pathophysiological toy to diagnostic tool. Point of view. Circulation 1992; 85: 1604-1612.
6. Earle KA, Misra M, Morocutti A, Barnes D, Stephens E, Chambers J et al. Microalbuminuria as a marker of silent myocardial ischaemia in insulin-dependent diabetic patients. Diabetologia 1996; 39: 854-856.
7. Kiat H, Berman DS, Maddahi J. Comparison of planar and tomographic exercise thallium 201 imaging methods for the evaluation of coronary artery disease. J Am Coll Cardiol 1989; 13; 613-616.
8. Picano E, Lattanzi F, Masini M, Distante A, L'Abbate A. High dose dipyridamole echocardiography test in effort angina pectoris. J Am Coll Cardiol 1986; 8: 848-854.
9. Picano E, Marini C, Pirelli S, Maffei S, Bolognese L, Chiriatti GP et al. on behalf of the EPIC study group. Safety of intravenous high-dose dipyridamole echocardiography. Am J Cardiol 1992; 70: 252-256.
10. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H et al. American Society of Echocardiography. Committee on standards, subcommittee on quantitation of two-dimensional echocardiograms: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989; 2: 358-367.
11. Picano E, Severi S, Michelassi C, Lattanzi F, Masini M, Orsini E et al. Prognostic importance of dipyridamole-echocardiography test in coronary artery disease. Circulation 1989; 80: 450-459.
12. Cheitlin MS, Alpert JS, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ et al. ACC/AHA guidelines for the clinical application of echocardiography: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). J Am Coll Cardiol 1997; 29: 862-879.
13. Tischler MD, Lee TH, Hirsch AT, Lord CP, Goldman L, Creager MA et al. Prediction of major cardiac vents after peripheral vascular surgery using dipyridamole echocardiography. Am J Cardiol 1991; 68: 593-597.
14. Picano E, Landi P, Bolognese L, Chiarandà G, Chiarella F, Seveso G et al. on behalf of the EPIC study group. Prognostic value of dipyridamole-echocardiography early after uncomplicated myocardial infarction: a large scale multicenter trial. Am J Med 1993; 11: 608-618.
15. van Daele M, McNeill AJ, Fioretti PM, Salustri A, Pozzoli M, El-Said EM et al. Prognostic value of dipyridamole sestamibi single-photon emission computed tomography and dipyridamole stress echocardiography for new cardiac events after an uncomplicated myocardial infarction. J Am Soc Echocardiogr 1994; 7: 370-80.
16. Picano E, Pingitore A, Conti U, Kozakova M, Boem A, Cabani E et al. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dipyridamole echocardiography. Eur Heart J 1993; 14: 1216-1222.
17. Pingitore A, Picano E, Quarta Colosso M, Reisenhofer B, Gigli G, Lucarini AR et al. The atropine factor in pharmacological stress echocardiography. J Am Coll Cardiol 1996; 27: 1164-1170.
18. Picano E, Dipyridamole-echocardiography test: the historical background and the physiologic basis. Eur Heart J 1989; 10: 365-376.
19. Diamond GA, Monkey business. Am J Cardiol 1986; 57: 471-476.